Not enough data
Ulrich’s repeated coverage of the "Biologics News and Reports Portal" indicates a strong focus on this specific topic within the healthcare and pharmaceutical industry. Given the frequency of announcements and press releases, Ulrich may be particularly interested in original news or expert commentary related to biologics, such as new developments, regulatory changes, or industry trends.
In terms of themes covered, it is evident that Ulrich concentrates mainly on healthcare & pharmaceutical topics alongside scientific aspects. If you have insights into groundbreaking advancements in biologics research or can provide expert analysis on key developments within this sector, your pitch stands a good chance with Ulrich.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ulrich Martin
STUTTGART, Germany I August 11, 2025 I Selecting the right target remains the most important decision to make in drug discovery and has to be seen in light of drug modality technologies available for a R&D organization. La Merie Publishing has released a new service offering which evaluates customer-selected targets for drug discovery in the […]
